Invest Like The Best: Latest Episode

Newest Invest Like The Best episode: The Flaw Behind... with US Healthcare (November 11, 2026). Key takeaway, summary and previous episodes from 1% Better.

Page updated by . New episodes are summarised within hours of release.

The Flaw Behind Everything Wrong With US Healthcare

Invest Like The Best with US Healthcare · Published · 1h 24m

The Flaw Behind Everything Wrong With US Healthcare

Key takeaway

Build your health stack the way you would an investment portfolio: layer interventions over time, test each one separately, and measure the results. Start by identifying one specific health risk you want to reduce, then work with a doctor to trial one treatment at a time. Track a marker like LDL or blood pressure at each step so you can see the marginal effect of each addition before combining them. Devin Nurmi, CEO of Ro, describes doing exactly this over 15 years with his father, a cardiologist, to bring his LDL from 130 down to 10. His argument is that chronic disease is an area-under-the-curve problem: the earlier and more precisely you act, the more lifetime risk you remove.

Episode overview

How broken are the incentives in U.S. healthcare, and what does a functioning patient-centered model actually look like? Devin Nurmi, CEO of Ro, the largest direct-to-consumer provider of GLP-1 medications in the United States, walks through the structural problems in American healthcare and how his company has tried to work around them. The conversation covers the past, present, and future of GLP-1 drugs, Ro's near-collapse and refounding in 2022, and the operational principles that drove a 10x revenue increase with fewer employees. - **The core diagnosis.** When the patient is not the customer, prices rise, transparency disappears, and care optimizes for everyone except the person receiving it. - **GLP-1s as a case study.** Direct-to-consumer distribution removed PBMs and insurers from the transaction, cut prices from roughly $1,300 to $149, and increased manufacturer margins simultaneously. - **The company rebuild.** After raising $500 million and growing only 9% in a year, Ro shed 30% of its staff, consolidated its brands, and instituted daily leadership check-ins for two years, eventually reaching 10x revenue with 30% fewer people. PBM stands for pharmacy benefit manager, the middlemen who negotiate drug prices between manufacturers and insurers.

Read the full Invest Like The Best episode summary for key insights, quotes and action items.

Previous Invest Like The Best episodes

  1. The Hidden Capital Crunch Behind Silicon Valley’s AI Boom
  2. Why Free Intelligence Won’t Change Everything
  3. How AI Is Repricing Every Software Company
  4. Why Every AI Lab Will Become a Biotech Company | Andrew Huberman
  5. Inside the Personal AI Assistant Growing 10% a Day | Instinct Founder

About this page

This page always shows the newest Invest Like The Best episode in the 1% Better library. We summarise each episode from its audio or captions within hours of release, so bookmark it to check what is new. Browse every Invest Like The Best summary and guide or all episode summaries.